Duchenne muscular dystrophy - What causes the increased membrane permeability in skeletal muscle?

被引:94
作者
Allen, David G. [1 ]
Whitehead, Nicholas P. [2 ]
机构
[1] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia
[2] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA
基金
英国医学研究理事会;
关键词
Muscular dystrophy; Dystrophin; Membrane permeability; Stretch-activated channels; Intracellular calcium; Reactive oxygen species; MDX MICE; ECCENTRIC CONTRACTIONS; PLASMA-MEMBRANE; CATION CHANNEL; GROWTH-FACTOR; CALCIUM; DAMAGE; MOUSE; TRPC1; MECHANISMS;
D O I
10.1016/j.biocel.2010.11.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Duchenne muscular dystrophy is a severe muscle wasting disease caused by a mutation in the gene for dystrophin - a cytoskeletal protein connecting the contractile machinery to a group of proteins in the cell membrane. At the end stage of the disease there is profound muscle weakness and atrophy. However, the early stage of the disease is characterised by increased membrane permeability which allows soluble enzymes such as creatine kinase to leak out of the cell and ions such as calcium to enter the cell. The most widely accepted theory to explain the increased membrane permeability is that the absence of dystrophin makes the membrane more fragile so that the stress of contraction causes membrane tears which provide the increase in membrane permeability. However other possibilities are that increases in intracellular calcium caused by altered regulation of channels activate enzymes, such as phospholipase A(2), which cause increased membrane permeability. Increases in reactive oxygen species (ROS) are also present in the early stages of the disease and may contribute both to membrane damage by peroxidation and to the channel opening. Understanding the earliest phases of the pathology are critical to therapies directed at minimizing the muscle damage. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 39 条
[1]
Calcium and the damage pathways in muscular dystrophy [J].
Allen, David G. ;
Gervasio, Othon L. ;
Yeung, Ella W. ;
Whitehead, Nicholas P. .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2010, 88 (02) :83-91
[2]
Caveolae, ion channels and cardiac arrhythmias [J].
Balijepalli, Ravi C. ;
Kamp, Timothy J. .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2008, 98 (2-3) :149-160
[3]
Defective membrane repair in dysferlin-deficient muscular dystrophy [J].
Bansal, D ;
Miyake, K ;
Vogel, SS ;
Groh, S ;
Chen, CC ;
Williamson, R ;
McNeil, PL ;
Campbell, KP .
NATURE, 2003, 423 (6936) :168-172
[4]
Ca2+-independent phospholipase A2 enhances store-operated Ca2+ entry in dystrophic skeletal muscle fibers [J].
Boittin, Francois-Xavier ;
Petermann, Olivier ;
Hirn, Carole ;
Mittaud, Peggy ;
Dorchies, Olivier M. ;
Roulet, Emmanuelle ;
Ruegg, Urs T. .
JOURNAL OF CELL SCIENCE, 2006, 119 (18) :3733-3742
[5]
Alterations in mitochondrial function as a harbinger of cardiomyopathy: Lessons from the dystrophic heart [J].
Burelle, Yan ;
Khairallah, Maya ;
Ascah, Alexis ;
Allen, Bruce G. ;
Deschepper, Christian F. ;
Petrof, Basil J. ;
Rosiers, Christine Des .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (02) :310-321
[6]
CLARKE MSF, 1993, J CELL SCI, V106, P121
[7]
Molecular mechanisms of muscular dystrophies: old and new players [J].
Davies, Kay E. ;
Nowak, Kristen J. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (10) :762-773
[8]
DUNCAN CJ, 1987, J CELL SCI, V87, P183
[9]
MEMBRANE ORGANIZATION OF THE DYSTROPHIN-GLYCOPROTEIN COMPLEX [J].
ERVASTI, JM ;
CAMPBELL, KP .
CELL, 1991, 66 (06) :1121-1131
[10]
Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice [J].
Friedrich, O ;
Both, M ;
Gillis, JM ;
Chamberlain, JS ;
Fink, RHA .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (01) :251-265